StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)

Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –

MeiraGTx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

MeiraGTx's total debt was $100.00M at Jun 30, 2026. For fiscal 2025 it was $49.69M, down 32.1% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.69M-32.1%
FY2024Dec 31, 2024$73.22M+1.5%
FY2023Dec 31, 2023$72.12M+1.5%
FY2022Dec 31, 2022$71.03M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$100.00M+36.1%
Q1 FY2026Mar 31, 2026$49.70M-32.1%
Q4 FY2025Dec 31, 2025$49.69M-31.9%
Q2 FY2025Jun 30, 2025$73.77M+1.5%
Q1 FY2025Mar 31, 2025$73.50M+1.5%
Q4 FY2024Dec 31, 2024$73.22M+1.5%
Q3 FY2024Sep 30, 2024$72.94M+1.5%
Q2 FY2024Jun 30, 2024$72.67M+1.5%
Q1 FY2024Mar 31, 2024$72.39M+1.5%
Q4 FY2023Dec 31, 2023$72.12M+1.5%
Q3 FY2023Sep 30, 2023$71.84M+1.4%
Q2 FY2023Jun 30, 2023$71.57M–
Q1 FY2023Mar 31, 2023$71.30M–
Q4 FY2022Dec 31, 2022$71.03M–
Q3 FY2022Sep 30, 2022$70.85M–

More MeiraGTx figures

See a number that looks wrong?